Vimovo (naproxen and esomeprazole magnesium) delayed-released tablets, marketed by AstraZeneca and Pozen Inc, are FDA approved for the symptomatic relief of arthritic conditions.
Brendan Whooley, PharmD
Advertisement
Articles by Brendan Whooley, PharmD
Advertisement
Latest Updated Articles
- Rx Product Profile: AstraZeneca and Pozen Inc's Vimovo
Published: November 18th 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Building a Unified Approach to Cardio Kidney Metabolic Health
2
Integrating Combination Therapies for Type 2 Diabetes and CKD
3
Targeting Mitochondrial Metabolism in Heart Failure: From Genetic Drivers to Fuel Modulation Therapies
4
Sotatercept Demonstrates Significant Reduction in Morbidity and Mortality Across Broader PAH Risk Groups
5
